Effects of endogenous histamine on seizure development of pentylenetetrazole-induced kindling in rats.

Li-San Zhang,Zhong Chen,Yu-Wen Huang,Wei-Wei Hu,Er-Qing Wei,Kazuhiko Yanai
DOI: https://doi.org/10.1159/000071263
IF: 3.4293
2003-01-01
Pharmacology
Abstract:This study was performed to investigate whether or not endogenous histamine can protect seizure development of pentylenetetrazole (PTZ)-induced kindling in rats. An intracerebroventricular (i.c.v.) injection with clobenpropit (5 and 10 mug), a representative H-3-antagonist, significantly prolonged the onset of kindling and inhibited the seizure stages in a dose-dependent manner. Its action was significantly reversed by both immepip (2 mug, i.c.v.), an H-3-agonist, and (alpha-fluoromethylhistidine (alpha-FMH, 10 mug, i.c.v.), a selective histidine decarboxylase inhibitor. alpha-FIVIH (20 mug, i.c.v.) and pyrilamine (1 and 5 mg/kg i.p.), a classical H-1-antagonist, markedly augmented the severity of seizure development of PTZ-induced kindling. Therefore, these results indicate that brain endogenous histamine plays a certain protective role on seizure development of PTZ-induced kindling in rats, and that its protective roles are mediated by H-1-receptors. Copyright (C) 2003 S. Karger AG, Basel.
What problem does this paper attempt to address?